1.The IL-33/ST2 Axis Protects Retinal Ganglion Cells by Modulating the Astrocyte Response After Optic Nerve Injury.
Zhigang QIAN ; Mengya JIAO ; Na ZHANG ; Xuhuan TANG ; Shiwang LIU ; Feng ZHANG ; Chenchen WANG ; Fang ZHENG
Neuroscience Bulletin 2025;41(1):61-76
IL-33 and its receptor ST2 play crucial roles in tissue repair and homeostasis. However, their involvement in optic neuropathy due to trauma and glaucoma remains unclear. Here, we report that IL-33 and ST2 were highly expressed in the mouse optic nerve and retina. Deletion of IL-33 or ST2 exacerbated retinal ganglion cell (RGC) loss, retinal thinning, and nerve fiber degeneration following optic nerve (ON) injury. This heightened retinal neurodegeneration correlated with increased neurotoxic astrocytes in Il33-/- mice. In vitro, rIL-33 mitigated the neurotoxic astrocyte phenotype and reduced the expression of pro-inflammatory factors, thereby alleviating the RGC death induced by neurotoxic astrocyte-conditioned medium in retinal explants. Exogenous IL-33 treatment improved RGC survival in Il33-/- and WT mice after ON injury, but not in ST2-/- mice. Our findings highlight the role of the IL-33/ST2 axis in modulating reactive astrocyte function and providing neuroprotection for RGCs following ON injury.
Animals
;
Interleukin-33/genetics*
;
Interleukin-1 Receptor-Like 1 Protein/genetics*
;
Optic Nerve Injuries/pathology*
;
Retinal Ganglion Cells/pathology*
;
Astrocytes/pathology*
;
Mice
;
Mice, Knockout
;
Mice, Inbred C57BL
;
Neuroprotection/physiology*
2.Association of IL33/ST2 signal pathway gene polymorphisms with myocardial infarction in a Chinese Han population.
Jin-hua YANG ; Fang-qin WU ; Qiang WEN ; Wen-cai ZHANG ; Yang-e WANG ; Xin XIONG ; Yan-wen SU ; Long-xian CHENG
Journal of Huazhong University of Science and Technology (Medical Sciences) 2015;35(1):16-20
This study investigated the relationship between IL-33/ST2 signal pathway gene polymorphisms and myocardial infarction (MI) in Han Chinese. A case-control association analysis was performed on a total of 490 MI patients (MI group) and 929 normal subjects (NC group). Sequenom Mass Array and Taqman genotyping technique were used to analyze the tag single nucleotide polymorphisms (SNPs) in the genes encoding IL-33, ST2, and IL-1RaP (rs11792633, rs1041973 and rs4624606). The results showed that the frequencies of rs4624606 genotypes AA, TT, AT were 0.031, 0.647, 0.322 in MI group and 0.026, 0.712, 0.263 in NC group, and the allele frequencies of A and T were 0.192, 0.808 in MI group and 0.157, 0.843 in NC group. There were significant differences in rs4624606 genotypes and allele frequencies between MI group and NC group (P<0.05). For rs11792633, the allele frequencies of C and T were 0.45, 0.55 in MI group and 0.454, 0.546 in NC group with no significant differences found between the two groups. Compared with genotype CC+TC, rs11792633 genotype TT had an increased risk of hypertension (P<0.05). However, there were no significant differences in the frequencies of rs11792633 genotypes between the two groups. No significant differences were noted in the frequencies of rs1041973 genotype and allele between the two groups. Logistic regression analysis showed that rs4624606 genotypes AT and AA+AT were both significantly associated with MI (AT: OR=1.325, P=0.029, 95% CI=1.03-1.705; AA+AT: OR=1.316, P=0.028, 95% CI=1.03-1.681) after factors such as age, gender, smoking, drinking, body mass index (BMI), triglyceride (TG) and cholesterol were adjusted. Those carrying rs4624606 genotype AT or AA+AT had an increased risk of MI. No associations were found between the polymorphisms of the other two loci with MI. It was concluded that, in the IL33/ST2 signal pathway, the A allele of rs4624606 polymorphism of IL-1RaP gene is a potential independent risk factor for MI, and the genotypes AA+AT and AT are associated with the incidence of MI.
China
;
Ethnic Groups
;
genetics
;
Female
;
Humans
;
Interleukin-1 Receptor-Like 1 Protein
;
Interleukin-33
;
Interleukins
;
genetics
;
metabolism
;
Male
;
Myocardial Infarction
;
genetics
;
Receptors, Cell Surface
;
genetics
;
metabolism
;
Signal Transduction
;
genetics
3.Establishment and application of TLR2 receptor-based cell screening model.
Ke LI ; Fang HUA ; Xiao-Xi LÜ ; Jiao-Jiao YU ; Zhuo-Wei HU
Acta Pharmaceutica Sinica 2013;48(5):694-699
TLR2 activity plays an important role in the pathogenesis of autoimmune diseases, tumor carcinogenesis and cardio-cerebrovascular diseases. To establish a TLR2 receptor-based cell screening model, NF-kappaB promoter-driven luciferase reporter plasmids were transfected into human embryonic kidney cells (HEK293) stably expressing human TLR2 and co-receptors CD14, TLR1 and TLR6. Single clones were then isolated and characterized. Using this screening system, a human TLR2-binding peptide C8 was obtained from the Ph.D.-7 Phage Display Peptide Library through biopanning and rapid analysis of selective interactive ligands (BRASIL). The binding characteristic of C8 with human TLR2 was evaluated by ELISA, flow cytometry and immunofluorescence. The NF-kappaB luciferase activity assay showed that C8 could activate the TLR2/TLR1 signaling pathway and induce the production of cytokines TNF-alpha and IL-6. In conclusion, the TLR2 receptor-based cell screening system is successfully established and a new TLR2-binding peptide is identified by using this system.
Bacteriophages
;
Drug Evaluation, Preclinical
;
Genes, Reporter
;
HEK293 Cells
;
Humans
;
Interleukin-6
;
metabolism
;
Lipopolysaccharide Receptors
;
metabolism
;
Luciferases
;
genetics
;
metabolism
;
Peptide Library
;
Peptides
;
metabolism
;
pharmacology
;
Promoter Regions, Genetic
;
Protein Binding
;
Signal Transduction
;
drug effects
;
Toll-Like Receptor 1
;
metabolism
;
Toll-Like Receptor 2
;
metabolism
;
Toll-Like Receptor 6
;
metabolism
;
Transfection
;
Tumor Necrosis Factor-alpha
;
metabolism
4.Effects of adenovirus-mediated bFGF, IL-1Ra and IGF-1 gene transfer on human osteoarthritic chondrocytes and osteoarthritis in rabbits.
Biao CHEN ; Jun QIN ; Hui WANG ; Jacques MAGDALOU ; Liaobin CHEN
Experimental & Molecular Medicine 2010;42(10):684-695
The study investigated the effects of adenovirus-mediated gene transfection of basic fibroblast growth factor (bFGF), bFGF combined with interleukin-1 receptor antagonist protein (IL-Ra) and/or insulin-like growth factor-1 (IGF-1) both in human osteoarthritis (OA) chondrocytes and rabbits OA model. Human OA chondrocytes were delivered by adenovirus-mediated bFGF, IL-Ra and IGF-1 vectors, respectively. Chondrocyte proliferation, glycosaminoglycan (GAG) content, expression of type II collagen, ADAMTS-5, MMP-13, MMP-3 and TIMP-1 were determined. Rabbit OA model was induced by anterior cruciate ligament transaction (ACLT) in knees. Adenoviral vectors encoding human bFGF, IL-Ra and IGF-1 were injected intraarticularly into the knee joints after ACLT. The effects of adenovirus- mediated gene transfection on rabbit OA were evaluated. In vitro, the transfected genes were expressed in cell supernatant of human OA chondrocytes. AdbFGF group significantly promoted chondrocyte proliferation, and increased GAG and type II collagen synthesis than in the OA group. As two or three genes were transfected in different combinations, there was significant enhancement on the GAG content, type II collagen synthesis, and TIMP-1 levels, while ADAMTS-5, MMP-13, and MMP-3 levels were reduced. In vivo, the transfected genes were expressed in synovial fluid of rabbits. Intraarticular delivery of bFGF enhanced the expression of type II collagen in cartilage and decreased cartilage Mankin score compared with the OA control group (P = 0.047; P < 0.01, respectively). Multiple-gene transfection in different combinations showed better results than bFGF transfection alone. This study suggests that bFGF gene transfection is effective in treating experimental OA. Multiple gene transfection has better biologic effects on OA.
Adenoviridae/*genetics
;
Animals
;
Chondrocytes/drug effects/*metabolism
;
Collagen Type II/genetics/metabolism
;
Fibroblast Growth Factor 2/*genetics
;
Gene Therapy/methods
;
Genetic Vectors/administration & dosage/*genetics
;
Humans
;
Insulin-Like Growth Factor I/*genetics/metabolism
;
Interleukin 1 Receptor Antagonist Protein/*genetics/metabolism
;
Interleukin-1/genetics/metabolism
;
Matrix Metalloproteinase 13/genetics/metabolism
;
Matrix Metalloproteinase 3/genetics/metabolism
;
Osteoarthritis/*therapy
;
Rabbits
;
Tissue Inhibitor of Metalloproteinase-1/genetics
;
Transfection

Result Analysis
Print
Save
E-mail